GLENMARK PHARMACEUTICALS
看多
已更新

GLENMARK PHARMA

122
With the strong recovery of the pharma sector, Glenmark is at the pre-virus levels and has been attempting to breakout of the range. The sector has been in consolidation for several days and it may attempt a breakout to slightly higher levels. The pharma sector may not face sell offs in the midst of the pandemic, in my opinion.
交易結束:目標達成

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。